Shufang Liang

13PUBLICATIONS
8CO-AUTHORS
Haematological tumoursBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSpeciation and extinction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 03, 2026
SUMOylated DDX3 Promotes HBV Replication and Tumor Growth of Hepatocellular Carcinoma via TRIM28-DDX3-KLF4α Signaling Axis.

|Sep 09, 2025
New Cyclic Lipopeptide Compounds for Efficiently Inhibiting Cellular Inflammation and Collagen-Induced Arthritis in Mice.

Yanni Ma, Xu Cao, Xiaoli Jin

|May 31, 2025
RUNX1/SLAMF3 Axis Drives Immunosuppression to Contribute to Colorectal Cancer Liver Metastasis by Blocking Phagocytosis and Depleting C1QC+ Tumor-Associated Macrophages.

Yinheng Luo, Xiaoli Jin, Lan Huang

|Feb 23, 2025
SENP1-mediated deSUMOylation of YBX1 promotes colorectal cancer development through the SENP1-YBX1-AKT signaling axis.

Zenghua Sheng, Shu Luo, Lan Huang

|Jan 22, 2025
Staphylococcus aureus nt5 gene mutation through CRISPR RNA-guided base editing weakens bacterial virulence and immune evasion.

Xinpeng Liu, Lan Huang, Yang Ye

|Sep 13, 2024
CRISETR: an efficient technology for multiplexed refactoring of biosynthetic gene clusters.

Fuqiang He, Xinpeng Liu, Min Tang

Pageof 3

Frequent Collaborators

1 joint publications

Yang Ye

1 joint publications

Peng Zhang

1 joint publications

Xixi Wang

1 joint publications

Zenghua Sheng